[Statin therapy as a protective factor regarding development of hypoxic hepatitis]

Med Klin Intensivmed Notfmed. 2014 Sep;109(6):443. doi: 10.1007/s00063-014-0417-5.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Cohort Studies
  • Critical Illness
  • Heart Arrest / complications
  • Hepatitis / diagnosis
  • Hepatitis / mortality
  • Hepatitis / prevention & control*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Hypoxia / diagnosis*
  • Hypoxia / mortality
  • Hypoxia / prevention & control*
  • Intensive Care Units*
  • Ischemia / diagnosis
  • Ischemia / mortality
  • Ischemia / prevention & control*
  • Liver / blood supply*
  • Liver Function Tests
  • Prospective Studies
  • Respiratory Insufficiency / complications
  • Shock / complications*
  • Shock / mortality
  • Survival Rate

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors